Dyno Therapeutics

Provider of Ai-based data-driven adeno-associated virus (AAV) engineering

placeCambridge, Massachusetts, United States calendar_todayFounded 2018 groups38 employees language dynotx.com

Registered entities

Innovation

19 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 1,510 times.

YearFilings
20226
20236
202410
202514
20267

Social engagement

Social engagement: 23.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Polaris Partners, CRV, Andreessen Horowitz.

Investor typeCountShare
Venture capital990%
Other / undisclosed110%

Recent activity

26 Jun 2026
Event
3rd Hope for Rare Foundation Science Conference
23 Jun 2026
Partnership
NVIDIA Healthcare
22 Jun 2026
Event
Turning AI Hype into Real-World Breakthroughs and Measurable Value for Pharma
Coming soon